BAM
Blueshift Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-513
| Closed | -$246K | – | 346 |
|
|
2023
Q1 | $246K | Sell |
513
-216
| -30% | -$103K | 0.1% | 263 |
|
|
2022
Q4 | $307K | Sell |
729
-867
| -54% | -$365K | 0.14% | 220 |
|
|
2022
Q3 | $666K | Sell |
1,596
-1,858
| -54% | -$775K | 0.14% | 210 |
|
|
2022
Q2 | $1.71M | Buy |
3,454
+2,927
| +555% | +$1.45M | 0.28% | 96 |
|
|
2022
Q1 | $297K | Sell |
527
-1,484
| -74% | -$836K | 0.03% | 614 |
|
|
2021
Q4 | $1.52M | Buy |
+2,011
| New | +$1.52M | 0.13% | 206 |
|
|
2021
Q3 | – | Sell |
-2,167
| Closed | -$1.4M | – | 1016 |
|
|
2021
Q2 | $1.4M | Sell |
2,167
-4,607
| -68% | -$2.97M | 0.08% | 280 |
|
|
2021
Q1 | $3.87M | Buy |
+6,774
| New | +$3.87M | 0.4% | 53 |
|
|
2020
Q4 | – | Sell |
-1,037
| Closed | -$535K | – | 698 |
|
|
2020
Q3 | $535K | Buy |
+1,037
| New | +$535K | 0.07% | 332 |
|
|
2019
Q4 | – | Sell |
-1,775
| Closed | -$591K | – | 797 |
|
|
2019
Q3 | $591K | Sell |
1,775
-3,409
| -66% | -$1.14M | 0.09% | 324 |
|
|
2019
Q2 | $1.62M | Buy |
5,184
+154
| +3% | +$48.1K | 0.21% | 143 |
|
|
2019
Q1 | $1.54M | Buy |
5,030
+3,597
| +251% | +$1.1M | 0.22% | 144 |
|
|
2018
Q4 | $333K | Buy |
+1,433
| New | +$333K | 0.06% | 453 |
|